HCP Safety App

Quick reference to immune-mediated adverse reactions associated with OPDIVO®

Please see links to U.S. Full Prescribing Information for OPDIVO at http://packageinserts.bms.com/pi/pi_opdivo.pdf and YERVOY® (ipilimumab) at http://packageinserts.bms.com/pi/pi_yervoy.pdf including BOXED WARNING regarding immune-mediated adverse reactions, for YEROY.

HCP Adverse Reactions Guide

Your quick reference to the immune-mediated adverse reactions associated with OPDIVO® treatment. The Immune-Mediated Adverse Reactions (IMARs) Guide App for OPDIVO treatment can be viewed on your phone or tablet providing on-the-go information at your fingertips.

- Learn more about clarifying and addressing OPDIVO associated IMARs

- Find detailed monitoring guidance and symptomatology in quick reference format

- Includes organ-specific IMAR algorithms

Please visit www.OPDIVO.com or call 1-855-OPDIVO-1 (1-855-673-4861) for more information.

From Bristol-Myers Squibb

For U.S. Healthcare Professionals